1. The mechanism by which insulin activates pyruvate dehydrogenase in rat epididymal adipose tissue was further investigated. 2. When crude extracts, prepared from tissue segments previously exposed to insulin (2m-i.u./ml) for 2min, were supplemented with Mg2+, Ca2+, glucose and hexokinase and incubated at 30°C, they displayed an enhanced rate of increase in pyruvate dehydrogenase activity compared with control extracts. 3. When similar extracts were instead supplemented with fluoride, ADP, creatine phosphate and creatine kinase, the rate of decrease in pyruvate dehydrogenase activity observed during incubation at 30°C was unaffected by insulin treatment. 4. It is suggested that insulin increases the fraction of pyruvate dehydrogenase present in the tissue in the active dephospho form by increasing the activity of pyruvate dehydrogenase phosphate phosphatase.
Since the discovery by Reed and co-workers (Linn et al., 1969a,b) that pyruvate dehydrogenase in several mammalian tissues exists both in an inactive phosphorylated form (pyruvate dehydrogenase phosphate) and an active unphosphorylated form (pyruvate dehydrogenase), a great deal of work has been done on factors that might control the degree of phosphorylation and thus the activity of this critical enzyme. In rat adipose tissue, pyruvate dehydrogenase activity has been shown to be subject to hormonal regulation (Jungas, 1970; Denton et al., 1971; Weiss et al., 1971) . When insulin or prostaglandin E1 is added to intact adipose-tissue cells, there is an increase in the assayable pyruvate dehydrogenase activity in tissue extracts . The activation of the enzyme results from an increase in the fraction of the enzyme present in the active unphosphorylated form Weiss et al., 1971; Taylor & Jungas, 1974) . This effect of insulin can be reversed by adrenaline or ACTH$ Jungas, 1971) . These hormonal influences are of special significance in the regulation oflipogenesis in rat adipose tissue, since the activity of pyruvate dehydrogenase appears to be one factor limiting the capacity of this pathway (Taylor & Jungas, 1974) .
Pyruvate dehydrogenase is unique among enzymes subject to covalent regulation via a phosphorylation-dephosphorylation mechanism in that it is confined to themitochondrial compartment ofthe cell. Further, neither the pyruvate dehydrogenase kinase or the pyruvate dehydrogenase phosphate phosphatase appear to be directly affected by cyclic AMP or cyclic GMP (Jungas, 1971; Hucho et al., 1972; Siess & Wieland, 1972; Randle & Denton, 1973) . As a first step in exploring the mechanisms by which insulin might influence the degree of phosphorylation of this mitochondrial protein, we have sought to determine whether it is the pyruvate dehydrogenase kinase, the pyruvate dehydrogenase phosphate phosphatase, or both whose activity is modulated by the hormone. We present here data suggesting that the major effect of insulin is to increase the activity of pyruvate dehydrogenase phosphate phosphatase.
Experimental

Methods
Tissue handling. Care of rats and dissection of epididymal adipose-tissue segments was as described previously . Segments obtained from two to four rats were pooled for use in each experiment. When the action of insulin was to be studied two pools of segments were formed each containing approx. g of tissue. The pools were separately incubated at 370C in lOml of KrebsHenseleit (1932) bicarbonate medium containing one-half the recommended calcium and 2mg of fructose per ml. The gas phase was C02+air (5:95) . After 30min the segments were transferred to 9ml of fresh medium of the same composition, which had been pre-warmed and pre-gassed. After a second incubation period of 10min there was added 1 ml of the same medium with or without insulin to give a final concentration of 1-4m-i.u./ml. From 1 to 4min later the segments were homogenized for assay of pyruvate dehydrogenase. In other experiments insulin or insulin plus adrenaline were present throughout the entire second incubation period.
Assay of pyruvate dehydrogenase phosphate phosphatase. A pool of adipose-tissue segments (1-1.6g) was homogenized by hand in4vol. ofice-cold medium [10mM-potassium phosphate-i mM-EGTA-1 mM-dithiothreitol-0.05 %Triton X-100 (pH 7.4)] in an allglass Ten Broeck apparatus. The homogenate was centrifuged at 700g for 2min at 2°C and left on icefora few minutes to permit the fatty layer to solidify. The aqueous infranatant was then recovered and divided into three portions. One portion was used to obtain an initial or zero-time value and was simply kept on ice until being assayed for pyruvate kinase. A second portion was supplemented with 1,25mM-CaCl2 and 5mM-MgCI2, incubated at 30°C for 35-45min, and assayed to reveal the maximum or fully activated pyruvate dehydrogenase content. To the third portion was added 1.25mm-CaCl2, 1.25mM-MgCl2, 1OmM-D-glucose and 1 unit (umol/ min) of hexokinase/ml. This portion was also incubated at 30°C and samples were withdrawn at suitable intervals and assayed for pyruvate dehydrogenase activity. The increase with time of dehydrogenase activity was taken as a reflexion of pyruvate dehydrogenase phosphate phosphatase activity. Pyruvate dehydrogenase activity was assayed by measuring the evolution of "CO2 from [1-_4C]-pyruvate during a 2min period at 370C as described previously . One unit of pyruvate dehydrogenase activity corresponds to I Jmol of C02/min at 371C.
Assay of pyruvate dehydrogenase kinase. Pooled tissue segments were homogenized and centrifuged as described above in a medium containing 10mM-potassium phosphate, 1 mM-EGTA, 1 mM-dithiothreitol, 1 % bovine serum albumin and 1.5mM-MgCl2. A portion of the infranatant was assayed for pyruvate dehydrogenase activity without further treatment. Another portion was supplemented with 8mM-NaF, 8puM-ADP, 4mM-creatine phosphate and 0.24unit (amol/min) of creatine kinase/ml.
It was then incubated at 25°C and samples were withdrawn at suitable intervals for pyruvate dehydrogenase assay. The decline with time of pyruvate dehydrogenase activity was taken as an indication of pyruvate dehydrogenase kinase activity.
Materials
Yeast hexokinase, rabbit muscle creatine kinase and creatine phosphate were obtained from Boehringer (Mannheim) Corp., New York, N.Y., U.S.A. Other suppliers were as described previously .
Results
Pyruvate dehydrogenasephosphatephosphatase
When crude extracts of adipose tissue containing EGTA are incubated at 30'C there is little change in their pyruvate dehydrogenase activity. If glucose and hexokinase are added to the extract to deplete it of ATP thereby depriving pyruvate dehydrogenase kinase of an essential substrate, and if Mg2+ and Ca2+ are added to satisfy the ionic requirements of pyruvate dehydrogenase phosphate phosphatase, there is an immediate rise in pyruvate dehydrogenase activity as shown in Fig. 1 . We assume that this rise in activity is the result ofenzymic dephosphorylation of pyruvate dehydrogenase phosphate, a process which has been carefully studied in Reed's laboratory (Linn et al., 1972; Hucho et al., 1972) .
In support of this assumption we show in Fig. 2 Effect ofinsulin on pyruvate dehydrogenase phosphate phosphatase The enzyme assay described above was used to determine whether exposure of tissue segments to insulin would alter phosphatase activity. In the experiment summarized in Fig. 4 , one of two paired pools of tissue segments was exposed to 1 m-i.u. of insulin/ml for 2min, a period too brief to allow a significant rise in pyruvate dehydrogenase activity to occur. The tissues were homogenized and the pyruvate dehydrogenase activity of each extract was monitored during incubation as shown in the Figure. The dehydrogenase activity of the extract prepared from the insulin-treated tissue rose about 65% more rapidly than in the control. Note that the initial dehydrogenase activity of the extracts was about the same, that is, there was no difference in the concentration of the substrate of the In experiments similar to those just described we could observe no effect of adrenaline at concen- Table 2 , extracts of tissue exposed to both insulin and adrenaline for 10min had lower phosphatase activity than extracts of paired segments exposed only to insulin. The percentage of maximum activation achieved in 6 min was nearly halved by the presence of adrenaline and now closely resembled that seen in extracts of control tissues.
Pyruvate dehydrogenase kinase
Ifcrude extracts ofadipose tissue are supplemented with NaF to block pyruvate dehydrogenase phosphate phosphatase, and provided with an ATP-generating system, incubation at 30°C leads to an abrupt fall in pyruvate dehydrogenase activity. From these requirements, we assumed that the declining dehydrogenase activity is the result of an enzymic phosphorylation of pyruvate dehydrogenase, as studied in detail in Reed's laboratory (Linn et al., 1972; Hucho et al., 1972) . Using this system as an assay for pyruvate dehydrogenase kinase in tissue extracts we have been unable to demonstrate any effect of insulin or adrenaline treatment of tissue segments. An example of this type of experiment is shown in Fig. 6 . Vol. 148 We have also studied pyruvate dehydrogenase kinase activity in extracts first incubated with an excess of Mg2+ and Ca2+ so as to generate maximal pyruvate dehydrogenase activity. Subsequent addition of fluoride and an ATP-generating system causes an abrupt fall in dehydrogenase activity, but hormonal treatment of the tissue is again without effect on the apparent kinase activity of the extracts.
Discussion
Mechanisms for changing enzyme activity in vivo may be divided into two broad classes termed 'rapidly' and 'slowly' reversible. Only changes of the slowly reversible type are sufficiently long-lived to be observed after the tissue contents have been diluted by homogenization. The data presented here indicate that pyruvate dehydrogenase phosphate phosphatase is activated by insulin in a slowly reversible manner. Although it is tempting to identify such slowly reversible changes with covalent modifications, other mechanisms must also be considered. For example, a ligand which is very tightly bound to the enzyme might dissociate from the enzyme so slowly as to allow its effect to be observed for extended periods after dilution. Alternatively, insulin could cause the accumulation of a substance with the property of catalysing conformational transitions of the enzyme. Dilution would freeze the enzyme in one conformation by removing the catalyst. This type ofregulation in which small molecules frequently serve as catalysts has been termed 'pre-conditioning' (Alpers et al., 1971; Paulus & Alpers, 1971 ).
At present there are three factors known to affect pyruvate dehydrogenase phosphate phosphatase activity: Mg2+ (Linn et al., 1969a) ; Ca2+ (Denton et al., 1972; Hucho et al., 1972 : Siess & Wieland, 1972 ; and free citrate (Taylor & Halperin, 1973) . Whether any of these factors is involved in the slowly reversible activation of pyruvate dehydrogenase phosphate phosphatase by insulin is not known. The activation is not readily explained by tight binding of calcium. In the present experiments, 1mm-EGTA was added to the homogenizing fluid for the purpose of chelating tissue calcium. Moreover, an excess of calcium was added during the phosphatase assay and yet elevated activity was observed. In other experiments not shown here, it was found that the addition of 1 mM-EGTA arrested pyruvate dehydrogenase phosphate phosphatase activity very rapidly in adipose-tissue extracts. Thus EGTA does successfully compete with the enzymes for calcium. We do not yet know how rapidly citrate dissociates from pyruvate dehydrogenase phosphate phosphatase.
The fact that the activation of the phosphatase by insulin could be blocked by adrenaline suggests that cyclic AMP may be at least indirectly involved in this regulatory system. Since it is well known that lipolysis and hence cellular concentrations of free fatty acids are affected by both adrenaline and insulin in this tissue, possible effects of fatty acids and their CoA thioesters on pyruvate dehydrogenase phosphate phosphatase deserve careful study.
An activation of pyruvate dehydrogenase phosphate phosphatase by insulin has been reported previously by Sica & Cuatrecasas (1973) . These workers used exogenous pyruvate dehydrogenase phosphate as substrate. The results of Sica & Cuatrecasas (1973) (Taylor et al., 1975) . In many tissues the major role of pyruvate dehydrogenase appears to be in the generation of ATP by providing acetyl-CoA for oxidation via the citric acid cycle. Thus regulation of pyruvate dehydrogenase activity by the mitochondrial ATP/ADP ratio seems most appropriate. However, in adipose tissue, a large fraction of the acetyl-CoA generated by pyruvate dehydrogenase is converted into fatty acids. Moreover, lipogenesis occurs at high rates at times when the cellular concentrations of ATP are high, for example in the presence of excess of glucose and insulin (Denton et al., 1966; Flatt, 1970) . If the mitochondrial ATP/ADP ratio is also high under these conditions, adipose tissue would require a mechanism for overcoming the feedback regulatory system based on this ratio. Such a mechanism appears to be provided by insulin acting on pyruvate dehydrogenase phosphate phosphatase. The (Cahill et al., 1958; Williams et al., 1968) , and apparently the increased flux through pyruvate dehydrogenase needed for lipogenesis is accomplished simply via elevations in liver pyruvate concentrations (Patzelt et al., 1973) . Severson et al. (1974) were unable to observe any action of insulin on pyruvate dehydrogenase phosphate phosphatase activity and their results thus differ from the present finding and the earlier report of Sica & Cuatrecasas (1973) . We do not understand the reasons for these discrepancies. In experiments similar to those summarized in Table 1 , Severson et al. (1974) reported a pyruvate dehydrogenase phosphate phosphatase activity of 26-28 (as the increase in endogenous pyruvate dehydrogenase activity, munits/g during 5 min) with or without prior exposure to insulin (5m-i.u./ml for 5min). Our values are twice as high in control tissue and more than three times higher with insulin-treated tissue. Among other minor differences in procedure it should be noted that Severson et al. (1974) froze the tissue during their extraction procedure, used a tenfold greater concentration of potassium phosphate in their extraction medium, and used a motor. driven tissue grinder. In our experience the composition of the medium used for tissue homogenization may be varied considerably without altering the observed insulin effect. For example, we have substituted l0mm-sucrose for the 10mM-potassium phosphate, replaced the 0.05% Triton X-100 with 1 % bovine serum albumin and replaced EGTA with EDTA without significantly modifying the insulin effect. In three experiments no mnagnesium or calcium was added during the phosphatase assay. This greatly diminished the rise in pyruvate dehydrogenase activity during incubation of the extracts, but the insulin effect was still observable. The control extracts now attained only 3.3 i 1.7 % of their maximal activation during the initial 5min of incubation whereas the extracts of insulin-treated tissue reached 6.7±1.2%. In a series of 12 experiments the length of exposure to insulin was varied between 1 and 5min and in each instance an effect of insulin was noted.
